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Despite the availability of highly effective vaccines, Bordetella pertussis incidence has been rapidly rising in highly vaccinated
populations. Recent outbreaks have received media attention, feeding concerns about the emergence of dangerous new strains
with increased virulence or that escape vaccine-induced immunity. To accelerate the study of this reemerging pathogen, we se-
quenced the genomes of 28 B. pertussis strains isolated during outbreaks from 2010 through 2012, making both strains and se-
quence data available to the scientific community.
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The Centers for Disease Control and Prevention classifieswhooping cough as a reemerging disease, documenting in-
creasing numbers of cases nearly every year, from hundreds per
year in the 1970s to 41,000 in 2012 (1). The recent high-profile
epidemics in California (in 2010) and Washington (in 2012) con-
tribute to growing concerns and feed speculation about the ongo-
ing evolution of Bordetella pertussis. To address these concerns, we
collected 28 strains of B. pertussis from these and other outbreaks
and made them available at the Biodefense and Emerging Infec-
tions Research Resources Repository for further study by others.
Here, we report the genome sequences of these 28 clinical isolates
derived from whooping cough hospital cases that occurred between
2010 and 2012. Genomic DNA was prepared using a phenol-
chloroform extraction method and ethanol precipitation (2). A com-
bination of 3- or 5-kb mate pair (~30 coverage) and 100-bp Illu-
mina paired-end reads (~50 coverage) were used for genome
sequence determination. After quality trimming, all reads were used
to generate assemblies with Celera assembler 6.1 (3) or Velvet assem-
bler (4). After improvement, all genomes had between 4 and 186
scaffolds containing 25 to 285 contigs. Underlying consensus se-
quences and gaps were improved using custom scripts developed at
the J. Craig Venter Institute (JCVI). The overall GC content in all
cases was ~67%, with genome sizes ranging from 3.83 Mb to 4.15 Mb
(average, 4.0 Mb). Up to 218 copies of insertion element IS481 and 95
tripartite transcarboxylate transporter (TTT) element were found in
any one B. pertussis genome, amounting to215 kb on average. All of
the B. pertussis isolates, irrespective of geographic location, belong to
the same multilocus sequence type and are nearly identical to each
other at the protein level (average 99% identity) in conserved regions
of the chromosome. However, the B. pertussis genomes were subject
to massive genome rearrangements and different gene losses that ac-
count for the majority of the diversity between strains. All the ge-
nomes were annotated using JCVI’s annotation pipeline (http://www
.jcvi.org) and were predicted to have between 3,750 and 4,193 genes.
As expected, mobile elements were overrepresented in these genomes
compared to in published Bordetella bronchiseptica genomes due to
the expansion of the repetitive elements. Over 1,000 core B. bron-
chiseptica genes were absent in all of the B. pertussis genomes. Many of
these genes are involved in capsule biosynthesis, alternate respiration,
nutrient acquisition, type VI secretion, and antibiotic resistance. All
B. pertussis isolates encoded pertussis toxin, filamentous hemagglutinin,
type III secretion system, adenylate cyclase, and other virulence factors.
The findings from this study suggest that currently circulating B. per-
tussis isolates in the United States are derived from a single genetic back-
ground. A full analysis of the virulence genes and evolution of B. pertussis
is under way and will be published in a subsequent report.
Nucleotide sequence accession numbers. The B. pertussis
whole-genome shotgun projects have been deposited for each iso-
late at DDBJ/EMBL/GenBank as described in Table 1. The version
described in this paper is the first version.
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TABLE 1 Characteristics of the 28 B. pertussis strains
B. pertussis strain name NCBI accession no. No. of contigs N50 (bp) Total length (bp) GC %
2250905 AXSU00000000 285 20,908 3,940,180 67.76
2356847 AXST00000000 179 31,198 3,907,019 67.86
2371640 AXSS00000000 193 33,462 3,904,605 67.88
STO1-SEAT-0006 AXSR00000000 49 139,362 4,028,421 67.77
STO1-SEAT-0007 AXSQ00000000 26 343,155 4,053,851 67.78
STO1-CHLA-0011 AXSP00000000 25 419,274 4,083,349 67.69
H897 AXSO00000000 173 36,602 3,938,675 67.81
H918 AXSN00000000 60 150,397 4,073,712 67.71
H921 AXSM00000000 48 164,785 4,064,086 67.73
H939 AXSL00000000 43 177,196 4,018,810 67.74
H973 AXSK00000000 62 112,367 4,014,250 67.81
STO1-SEAT-0004 AXSJ00000000 121 52,170 3,839,596 67.9
I002 AXSI00000000 63 102,522 4,047,567 67.74
I036 AXSH00000000 46 189,616 4,057,285 67.74
I176 AXSG00000000 33 266,526 4,045,246 67.78
STO1-CHLA-0006 AXSF00000000 65 134,387 4,044,283 67.79
CHLA-15 AXSD00000000 138 46,158 3,844,206 67.89
CHLA-13 AXSE00000000 95 74,009 4,029,822 67.79
CHLA-20 AXSC00000000 131 46,140 3,828,499 67.9
CHLA-26 AXSB00000000 41 264,509 4,045,408 67.8
STO1-CHOC-0016 AXSA00000000 54 122,855 4,033,849 67.79
STO1-CHOC-0017 AXRZ00000000 108 45,197 4,050,208 67.8
STO1-CHOC-0018 AXRY00000000 127 43,391 4,051,577 67.81
STO1-CHOC-0019 AXRX00000000 120 52,255 4,150,262 67.72
STO1-CHOC-0021 AXRW00000000 56 115,723 4,027,480 67.8
STO1-CHOC-0008 AXRV00000000 124 50,507 3,834,602 67.9
STO1-CHOM-0012 AXRU00000000 37 222,972 4,065,443 67.71
STO1-CNMC-0004 AXSV00000000 149 46,159 3,855,042 67.88
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